Merck & Company, Inc. Common Stock (new) (MRK) dividends
MRK on New York Stock Exchange, Health Care
Sign in to get an email when it declares a dividend.
Merck & Company, Inc. Common Stock (new) dividend: key facts
Own Merck & Company, Inc. Common Stock (new)? See exactly what it will pay you
Add your shares to a free DiviCompass portfolio to see your next MRK dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.
Price history
End-of-day closes on New York Stock Exchange in USD. Dots mark ex-dividend dates.
Dividend history
Declared dividends. Special dividends are marked and excluded from yield and forecasts.
| Ex-dividend | Payment | Per share | Currency | Type |
|---|---|---|---|---|
| 15 Sep 2026 | Paid 7 Oct 2026 | $0.85 | USD | Quarterly |
| 15 Jun 2026 | Paid 8 Jul 2026 | $0.85 | USD | Quarterly |
| 16 Mar 2026 | Paid 7 Apr 2026 | $0.85 | USD | Quarterly |
| 15 Dec 2025 | Paid 8 Jan 2026 | $0.85 | USD | Quarterly |
| 15 Sep 2025 | Paid 7 Oct 2025 | $0.81 | USD | Quarterly |
| 16 Jun 2025 | Paid 8 Jul 2025 | $0.81 | USD | Quarterly |
| 17 Mar 2025 | Paid 7 Apr 2025 | $0.81 | USD | Quarterly |
| 16 Dec 2024 | Paid 8 Jan 2025 | $0.81 | USD | Quarterly |
| 16 Sep 2024 | Paid 7 Oct 2024 | $0.77 | USD | Quarterly |
| 17 Jun 2024 | Paid 8 Jul 2024 | $0.77 | USD | Quarterly |
| 14 Mar 2024 | Paid 5 Apr 2024 | $0.77 | USD | Quarterly |
| 14 Dec 2023 | Paid 8 Jan 2024 | $0.77 | USD | Quarterly |
| 14 Sep 2023 | Paid 6 Oct 2023 | $0.73 | USD | Quarterly |
| 14 Jun 2023 | Paid 10 Jul 2023 | $0.73 | USD | Quarterly |
| 14 Mar 2023 | Paid 10 Apr 2023 | $0.73 | USD | Quarterly |
| 14 Dec 2022 | Paid 9 Jan 2023 | $0.73 | USD | Quarterly |
| 14 Sep 2022 | Paid 7 Oct 2022 | $0.69 | USD | Quarterly |
| 14 Jun 2022 | Paid 8 Jul 2022 | $0.69 | USD | Quarterly |
| 14 Mar 2022 | Paid 7 Apr 2022 | $0.69 | USD | Quarterly |
| 14 Dec 2021 | Paid 7 Jan 2022 | $0.69 | USD | Quarterly |
| 14 Sep 2021 | Paid 7 Oct 2021 | $0.65 | USD | Quarterly |
| 14 Jun 2021 | Paid 7 Jul 2021 | $0.65 | USD | Quarterly |
| 12 Mar 2021 | Paid 7 Apr 2021 | $0.65 | USD | Quarterly |
| 14 Dec 2020 | Paid 8 Jan 2021 | $0.65 | USD | Quarterly |
Five-year outlook
Estimates, not forecasts of what will be paid: dividends can be cut at any time.
| Period | Per share | Currency | Yield at today's price | Confidence |
|---|---|---|---|---|
| Next 12 months | $3.5841 | USD | 2.60% | High |
| Year 2 | $3.7782 | USD | 2.74% | Medium |
| Year 3 | $3.9829 | USD | 2.89% | Medium |
| Year 4 | $4.1986 | USD | 3.05% | Low |
| Year 5 | $4.4259 | USD | 3.21% | Low |
How we got these figures. Raised 15 years in a row; grown at 5.4% a year (its recent pace).
With no growth at all, each year would be $3.40.
Reported financials
Annual figures from filings, converted to units.
| Year to | Revenue | Net income | EPS | Free cash flow | Source |
|---|---|---|---|---|---|
| 31 Dec 2025US-GAAP USD | $65.01bn | $18.25bn | $7.28 | $12.36bnDerived | Source (opens in a new tab) |
| 31 Dec 2024US-GAAP USD | $64.17bn | $17.12bn | $6.74 | $18.10bnDerived | Source (opens in a new tab) |
| 31 Dec 2023US-GAAP USD | $60.12bn | $365.0m | $0.14 | $9.14bnDerived | Source (opens in a new tab) |
| 31 Dec 2022US-GAAP USD | $59.28bn | $14.52bn | $5.71 | $14.71bnDerived | Source (opens in a new tab) |
| 31 Dec 2021US-GAAP USD | $48.70bn | $13.05bn | $5.14 | $8.67bnDerived | Source (opens in a new tab) |
| 31 Dec 2020US-GAAP USD | $47.99bn | $7.07bn | $2.78 | $5.57bnDerived | Source (opens in a new tab) |
About Merck & Company, Inc. Common Stock (new)
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda (pembrolizumab), a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co.
From Wikipedia, CC BY-SA 4.0.
Next 12 months
| 15 Dec 2026Ex-dividend | USD | $0.8960Estimate |
| 16 Mar 2027Ex-dividend | USD | $0.8960Estimate |
| 15 Jun 2027Ex-dividend | USD | $0.8960Estimate |
| 15 Sep 2027Ex-dividend | USD | $0.8960Estimate |
Estimate confidence: High
Financial health
A summary of the scores below, each 0 to 100. Based on the year to 31 Dec 2025.
Company news
- Merck & Co., Inc.: Director or officer change (8-K)18 Nov 2026 · SEC EDGAR
Dividend data and price last updated 18 Nov 2026.